Rankings
▼
Calendar
TKNO FY 2022 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena
TKNO
Alpha Teknova, Inc.
$133M
FY 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$41M
+12.3% YoY
Gross Profit
$17M
42.2% margin
Operating Income
-$50M
-119.9% margin
Net Income
-$47M
-114.6% margin
EPS (Diluted)
$-1.69
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$56M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$152M
Total Liabilities
$52M
Stockholders' Equity
$100M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$41M
$37M
+12.3%
Gross Profit
$17M
$18M
-0.8%
Operating Income
-$50M
-$12M
-313.5%
Net Income
-$47M
-$10M
-384.2%
← Q4 2021
All Quarters
Q1 2022 →